MECHANISMS OF ANTI-CD4-MEDIATED DEPLETION AND IMMUNOTHERAPY - A STUDY USING A SET OF CHIMERIC ANTI-CD4 ANTIBODIES

被引:0
|
作者
ALTERS, SE
SAKAI, K
STEINMAN, L
OI, VT
机构
[1] STANFORD UNIV,MED CTR,SCH MED,DEPT NEUROL H-3160,STANFORD,CA 94305
[2] STANFORD UNIV,MED CTR,SCH MED,DEPT NEUROL PEDIAT & GENET,STANFORD,CA 94305
[3] STANFORD UNIV,MED CTR,SCH MED,PROGRAM CANC BIOL,STANFORD,CA 94305
[4] BECTON DICKINSON IMMUNOCYTOMETRY SYST,SAN JOSE,CA 95131
来源
JOURNAL OF IMMUNOLOGY | 1990年 / 144卷 / 12期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:4587 / 4592
页数:6
相关论文
共 50 条
  • [31] Collateral Damage: What Effect Does Anti-CD4 and Anti-CD8α Antibody-Mediated Depletion Have on Leukocyte Populations?
    Jung, So Ri
    Suprunenko, Tamara
    Ashhurst, Thomas M.
    King, Nicholas J. C.
    Hofer, Markus J.
    JOURNAL OF IMMUNOLOGY, 2018, 201 (07): : 2176 - 2186
  • [32] Anti-CD4 monoclonal antibody therapy
    Delmonice, FL
    Cosimi, AB
    CLINICAL TRANSPLANTATION, 1996, 10 (05) : 397 - 403
  • [33] EFFECT OF ANTI-CD4 ON CD4 SUBSETS .1. ANTI-CD4 PREFERENTIALLY DELETES RESTING, NAIVE CD4 CELLS AND SPARES ACTIVATED CD4 CELLS
    CHACE, JH
    COWDERY, JS
    FIELD, EH
    JOURNAL OF IMMUNOLOGY, 1994, 152 (02): : 405 - 412
  • [34] ACTIVE SUPPRESSION INDUCED BY ANTI-CD4
    HUTCHINGS, PR
    COOKE, A
    DAWE, K
    WALDMANN, H
    ROITT, IM
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (04) : 965 - 968
  • [35] A comparative study into the mechanisms of action of anti-tumor necrosis factor α, anti-CD4, and combined anti-tumor necrosis factor α/anti-CD4 treatment in early collagen-induced arthritis
    Marinova-Mutafchieva, L
    Williams, RO
    Mauri, C
    Mason, LJ
    Walmsley, MJ
    Taylor, PC
    Feldmann, M
    ARTHRITIS AND RHEUMATISM, 2000, 43 (03): : 638 - 644
  • [36] SELECTIVE T-CELL SUBSET DEPLETION WITH ANTI-CD4 AND ANTI-CD8 INTACT RICIN IMMUNOTOXINS
    IZQUIERDO, M
    BALBOA, MA
    FIGUERA, A
    LOPEZBOTET, M
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1988, 74 (02): : 300 - 304
  • [37] CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized™ monoclonal anti-CD4 treatment of active rheumatoid arthritis
    Mason, U
    Aldrich, J
    Breedveld, F
    Davis, CB
    Elliott, M
    Jackson, M
    Jorgensen, C
    Keystone, E
    Levy, R
    Tesser, J
    Totoritis, M
    Truneh, A
    Weisman, M
    Wiesenhutter, C
    Yocum, D
    Zhu, J
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (02) : 220 - 229
  • [38] Mechanisms involved in synergistic anticancer immunity of Anti-4-1BB and Anti-CD4 therapy
    Choi, Beom K.
    Kim, Young H.
    Kang, Woo J.
    Lee, Sun K.
    Kim, Kwang H.
    Shin, Su M.
    Yokoyama, Wayne M.
    Kim, Tae Y.
    Kwon, Byoung S.
    CANCER RESEARCH, 2007, 67 (18) : 8891 - 8899
  • [39] Expression of Anti-CD4 Human/Murine Chimeric Antibody and Their Killer Tumor Activity
    沈关心
    朱志刚
    朱慧芬
    邵静芳
    王晓林
    熊伟
    Journal of Tongji Medical University, 1998, (01) : 1 - 4
  • [40] Expression of anti-CD4 human/murine chimeric antibody and their killer tumor activity
    Shen Guanxin
    Zhu Zhigang
    Zhu Huifen
    Shao Jingfang
    Wang Xiaolin
    Xiong Wei
    Current Medical Science, 1998, 18 (1) : 1 - 4